Unilever Consumer Care Limited (DSE:UNILEVERCL)
2,040.00
-1.60 (-0.08%)
At close: Aug 13, 2026
Unilever Consumer Care Revenue
Unilever Consumer Care had revenue of 729.62M BDT in the quarter ending June 30, 2026, a decrease of -8.40%. This brings the company's revenue in the last twelve months to 3.42B, down -0.04% year-over-year. In the year 2025, Unilever Consumer Care had annual revenue of 3.57B with 5.45% growth.
Revenue (ttm)
3.42B
Revenue Growth
-0.04%
P/S Ratio
11.49
Revenue / Employee
100.63M
Employees
34
Market Cap
39.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.57B | 184.54M | 5.45% |
| Dec 31, 2024 | 3.38B | -570.90M | -14.44% |
| Dec 31, 2023 | 3.95B | -144.37M | -3.52% |
| Dec 31, 2022 | 4.10B | -44.99M | -1.09% |
| Dec 31, 2021 | 4.14B | 674.61M | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Square Pharmaceuticals PLC. | 83.53B |
| Beximco Pharmaceuticals PLC. | 53.93B |
| Renata | 44.93B |
| The ACME Laboratories | 40.05B |
| Beacon Pharmaceuticals | 15.57B |
| The IBN SINA Pharmaceutical Industry | 13.48B |
| Navana Pharmaceuticals | 10.57B |
| Techno Drugs | 3.10B |